Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Work detail

Bookitis Pick

Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmi...

J. MorganrothE. Neil Moore2 editions

This page groups all known editions belonging to the same underlying work.

Search books Open lead author

Overview

Shared work-level identity and catalog context.

2 credited authorsSearch language english

Bookitis keeps work pages focused on the shared book identity and the editions that actually belong to it. Unrelated books should not appear here as primary content.

Contributors

People credited with this work in the active catalog.

J. Morganroth
Author profile in the active Bookitis catalog
Open Author
E. Neil Moore
Author profile in the active Bookitis catalog
Open Author

Editions

Publication-specific versions linked to this work only.

Risk/Benefit Analysis for the U...J. Morganroth, E. Neil Moore
RA
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
J. Morganroth, E. Neil Moore | Springer London, Limited | 2012
1 views
Risk/Benefit Analysis for the U...J. Morganroth, E. Neil Moore
RA
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
J. Morganroth, E. Neil Moore | Springer | Oct 17, 2011
1 views